| Serial Number | 98338379 |
| Word Mark | WECARELIFE |
| Filing Date | Tuesday, January 2, 2024 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, November 5, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 10, 2024 |
| Description of Mark | The mark consists of a bigger solid circle shape, and a smaller solid circle shape partially overlapped with the bigger circle on the upper right part of the bigger circle, and a medium size circle appearing within the bigger circle on the lower left part. To the right of the circle shape is the stylized wording "WeCare", and the word "life" in smaller font is located on the upper right of the wording "WeCare". |
| Goods and Services | Delivery agents in the form of nanoparticles that facilitate the delivery of nutritional supplements; Drug delivery agents in the form of nanoparticles that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes |
| Pseudo Mark | WE CARE LIFE |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Translation of Words in Mark | The wording WECARELIFE has no meaning in a foreign language. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 2, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | WeCareLife Biotech Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Daxing, Beijing 102629 CN |
| Party Name | WeCareLife Biotech Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Daxing, Beijing 102629 CN |
| Event Date | Event Description |
| Tuesday, January 2, 2024 | NEW APPLICATION ENTERED |
| Tuesday, April 16, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 21, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 10, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 10, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 5, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 16, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, July 30, 2024 | ASSIGNED TO EXAMINER |
| Thursday, August 1, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |